Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/24258149http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24258149http://www.w3.org/2000/01/rdf-schema#comment"

Objective

To determine the long-term effect of natalizumab (NTZ) treatment on the expression of integrins and chemokine receptors involved in the migration of T cells towards the central nervous system (CNS).

Methods

We drew the blood of 23 patients just before starting NTZ therapy and every 12 months thereafter, for up to 48 months of treatment. We assessed the ex-vivo expression of phenotype markers (CCR7 and CD45RA), CNS-addressing integrins (CD11a, CD49d and CD29) and chemokine receptors (CXCR3 and CCR6) in CD4+ or CD8+ T-cell subsets by flow cytometry.

Results

As compared to the pre-NTZ values, there was a marked increase in central memory (CCR7+/CD45RA-) CD4+ T cells and in effector memory (CCR7-/CD45RA-) CD8+ T cells at 12 and 24 months. In addition to an expected downregulation of both VLA-4 subunits (CD49d/CD29), we also found decreased T-cell expression of CXCR3 at 12 months, and of CD11a (LFA-1 αL subunit) at 12 months, but mostly at 24 months of NTZ treatment.

Conclusion

Our data show a nadir of CD11a expression at 2 years of NTZ treatment, at the peak of incidence of progressive multifocal leukoencephalopathy (PML), indirectly suggesting that a lack of these molecules may play a role in the onset of PML in NTZ-treated patients."xsd:string
http://purl.uniprot.org/citations/24258149http://purl.org/dc/terms/identifier"doi:10.1177/1352458513513208"xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/author"Canales M."xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/author"Pantaleo G."xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/author"Mathias A."xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/author"Schluep M."xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/author"Du Pasquier R.A."xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/author"Jilek S."xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/author"Lysandropoulos A."xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/date"2014"xsd:gYear
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/name"Mult Scler"xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/pages"837-842"xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/title"Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 alpha-chain (CD11a) in MS patients."xsd:string
http://purl.uniprot.org/citations/24258149http://purl.uniprot.org/core/volume"20"xsd:string
http://purl.uniprot.org/citations/24258149http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/24258149
http://purl.uniprot.org/citations/24258149http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/24258149
http://purl.uniprot.org/uniprot/#_B2RAL6-mappedCitation-24258149http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24258149
http://purl.uniprot.org/uniprot/#_B4DQ77-mappedCitation-24258149http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24258149
http://purl.uniprot.org/uniprot/#_B4E021-mappedCitation-24258149http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24258149
http://purl.uniprot.org/uniprot/#_P20701-mappedCitation-24258149http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24258149
http://purl.uniprot.org/uniprot/B4E021http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24258149
http://purl.uniprot.org/uniprot/B4DQ77http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24258149
http://purl.uniprot.org/uniprot/P20701http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24258149
http://purl.uniprot.org/uniprot/B2RAL6http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24258149
▶